June 19th 2025
First-line systemic therapy plus radiation therapy improved PFS vs second-line systemic therapy with or without radiation in hepatocellular carcinoma.
Adjuvant Nivolumab Misses DFS End Point in Locally Advanced High-Risk RCC
January 27th 2024Treatment with nivolumab did not reach the primary endpoint of disease-free survival when compared with placebo in patients with localized renal cell carcinoma at high risk of relapse after nephrectomy in the phase 3 CheckMate 914 trial.
The Role of Registered Nurses in the Multidisciplinary Treatment of Advanced RCC
December 14th 2023Nurses play a key role in kidney cancer care by educating patients on medications, closely monitoring and managing side effects, coordinating care, providing emotional support, and serving as the first line of communication with patients about treatment concerns.